2673189 Alberta Inc
$30,000.00 CAD
≈ 5 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- April 1, 2026 – March 31, 2027
- Reference
- nrc-cnrc:172-2025-2026-Q4-1041190
Published purpose
RNARevive is developing a proprietary self-amplifying RNA platform for advanced regenerative therapeutics. This project involves the design, synthesis, and in vitro validation of RNA constructs targeting key regenerative pathways. The Graduate will support the technical optimization of the RNA architecture to achieve high-fidelity protein expression.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions